APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

PET Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032

Report ID 174024330219 December 2025197 pages

Choose your research edition.

Industry ResearchPET Radiopharmaceuticals Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal PET Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PET Radiopharmaceuticals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global PET Radiopharmaceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of PET Radiopharmaceuticals include Cardinal Health Inc. (U.S.), Bayer AG (Germany), Nordion, Inc. (Canada), Mallinckrodt plc (Ireland), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), GE Healthcare (U.K.), Eczacibasi-Monrol Nuclear Products (Turkey) and Bracco Imaging S.p.A (Italy), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for PET Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PET Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for PET Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PET Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PET Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for PET Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

PET Radiopharmaceuticals Segment by Company

Cardinal Health Inc. (U.S.)

Bayer AG (Germany)

Nordion, Inc. (Canada)

Mallinckrodt plc (Ireland)

Lantheus Medical Imaging, Inc. (U.S.)

IBA Molecular Imaging (Belgium)

GE Healthcare (U.K.)

Eczacibasi-Monrol Nuclear Products (Turkey)

Bracco Imaging S.p.A (Italy)

Advanced Accelerator Applications S.A. (France)

PET Radiopharmaceuticals Segment by Type

F-18

Ru-82

Others

PET Radiopharmaceuticals Segment by Application

Neurology

Cardiology

Oncology

Others

PET Radiopharmaceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PET Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PET Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PET Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of PET Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of PET Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PET Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PET Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. F-18 Major Manufacturers Table 3. Ru-82 Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global PET Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Neurology Major Manufacturers Table 7. Cardiology Major Manufacturers Table 8. Oncology Major Manufacturers Table 9. Others Major Manufacturers Table 10. PET Radiopharmaceuticals Industry Trends Table 11. PET Radiopharmaceuticals Industry Drivers Table 12. PET Radiopharmaceuticals Industry Opportunities and Challenges Table 13. PET Radiopharmaceuticals Industry Restraints Table 14. Global PET Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global PET Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 16. Global PET Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 17. Global PET Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 18. Global PET Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 19. Global PET Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global PET Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 21. Global PET Radiopharmaceuticals Sales by Region (2027-2032) & (K Units) Table 22. Global PET Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 23. Global PET Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 24. Global PET Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 26. Global PET Radiopharmaceuticals Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026) Table 28. Global PET Radiopharmaceuticals Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global PET Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global PET Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global PET Radiopharmaceuticals Manufacturers, Product Type & Application Table 32. Global PET Radiopharmaceuticals Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global PET Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global PET Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 37. Global PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 38. Global PET Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 39. Global PET Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 40. Global PET Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 42. Global PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 43. Global PET Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 44. Global PET Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 45. Global PET Radiopharmaceuticals Price by Type (2021-2026) & (US$/Unit) Table 46. Global PET Radiopharmaceuticals Price by Type (2027-2032) & (US$/Unit) Table 47. Global PET Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 49. Global PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 50. Global PET Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 51. Global PET Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 52. Global PET Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 54. Global PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 55. Global PET Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 56. Global PET Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 57. Global PET Radiopharmaceuticals Price by Application (2021-2026) & (US$/Unit) Table 58. Global PET Radiopharmaceuticals Price by Application (2027-2032) & (US$/Unit) Table 59. Cardinal Health Inc. (U.S.) Company Information Table 60. Cardinal Health Inc. (U.S.) Business Overview Table 61. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio Table 63. Cardinal Health Inc. (U.S.) Recent Development Table 64. Bayer AG (Germany) Company Information Table 65. Bayer AG (Germany) Business Overview Table 66. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio Table 68. Bayer AG (Germany) Recent Development Table 69. Nordion, Inc. (Canada) Company Information Table 70. Nordion, Inc. (Canada) Business Overview Table 71. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolio Table 73. Nordion, Inc. (Canada) Recent Development Table 74. Mallinckrodt plc (Ireland) Company Information Table 75. Mallinckrodt plc (Ireland) Business Overview Table 76. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio Table 78. Mallinckrodt plc (Ireland) Recent Development Table 79. Lantheus Medical Imaging, Inc. (U.S.) Company Information Table 80. Lantheus Medical Imaging, Inc. (U.S.) Business Overview Table 81. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio Table 83. Lantheus Medical Imaging, Inc. (U.S.) Recent Development Table 84. IBA Molecular Imaging (Belgium) Company Information Table 85. IBA Molecular Imaging (Belgium) Business Overview Table 86. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio Table 88. IBA Molecular Imaging (Belgium) Recent Development Table 89. GE Healthcare (U.K.) Company Information Table 90. GE Healthcare (U.K.) Business Overview Table 91. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolio Table 93. GE Healthcare (U.K.) Recent Development Table 94. Eczacibasi-Monrol Nuclear Products (Turkey) Company Information Table 95. Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview Table 96. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio Table 98. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development Table 99. Bracco Imaging S.p.A (Italy) Company Information Table 100. Bracco Imaging S.p.A (Italy) Business Overview Table 101. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolio Table 103. Bracco Imaging S.p.A (Italy) Recent Development Table 104. Advanced Accelerator Applications S.A. (France) Company Information Table 105. Advanced Accelerator Applications S.A. (France) Business Overview Table 106. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolio Table 108. Advanced Accelerator Applications S.A. (France) Recent Development Table 109. North America PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 110. North America PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 111. North America PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 112. North America PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 113. North America PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 114. North America PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 115. North America PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 116. North America PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 117. North America PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 118. North America PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 119. North America PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 120. North America PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 121. North America PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. North America PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 126. North America PET Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 127. North America PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 128. North America PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 129. United States PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 130. Canada PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 131. Europe PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 134. Europe PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 135. Europe PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Europe PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Europe PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 140. Europe PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 141. Europe PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Europe PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Europe PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Europe PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 148. Europe PET Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 149. Europe PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Europe PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Germany PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 152. France PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 153. U.K. PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 154. Italy PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 155. Netherlands PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 156. China PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 157. China PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 158. China PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 159. China PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 160. China PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 163. China PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 164. China PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 165. China PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 166. China PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 171. Asia PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 172. Asia PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 177. Asia PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 178. Asia PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Asia PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 185. Asia PET Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 186. Asia PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 189. South Korea PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 190. India PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 191. Australia PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 194. SAMEA PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 197. SAMEA PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 198. SAMEA PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 203. SAMEA PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 204. SAMEA PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. SAMEA PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 211. SAMEA PET Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 212. SAMEA PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 215. Argentina PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 216. Chile PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 217. Colombia PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 218. Peru PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 220. Israel PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 221. UAE PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 222. Turkey PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 223. Iran PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 224. Egypt PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. PET Radiopharmaceuticals Distributors List Table 228. PET Radiopharmaceuticals Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. PET Radiopharmaceuticals Image Figure 2. Global PET Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PET Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 4. F-18 Image Figure 5. Ru-82 Image Figure 6. Others Image Figure 7. Global PET Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global PET Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 9. Neurology Image Figure 10. Cardiology Image Figure 11. Oncology Image Figure 12. Others Image Figure 13. Global PET Radiopharmaceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 15. Global PET Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global PET Radiopharmaceuticals Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global PET Radiopharmaceuticals Revenue Market Share by Region (2021-2032) Figure 18. Global PET Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 19. Global PET Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global PET Radiopharmaceuticals Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico PET Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 22. Europe PET Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 23. China PET Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) PET Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa PET Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 26. Global PET Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global PET Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global PET Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global PET Radiopharmaceuticals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global PET Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 32. Global PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global PET Radiopharmaceuticals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global PET Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 35. Global PET Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global PET Radiopharmaceuticals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global PET Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 38. Global PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global PET Radiopharmaceuticals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global PET Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 41. North America PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 42. North America PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 43. North America PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 44. North America PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 45. North America PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 46. North America PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 47. Europe PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 48. Europe PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 49. Europe PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 50. Europe PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 51. Europe PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 52. Europe PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 53. China PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 54. China PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 55. China PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 56. China PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 57. Asia PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 58. Asia PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 59. Asia PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 60. Asia PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 61. Asia PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 62. Asia PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 63. SAMEA PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 64. SAMEA PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 65. SAMEA PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 66. SAMEA PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 67. SAMEA PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 68. SAMEA PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 69. PET Radiopharmaceuticals Value Chain Figure 70. Manufacturing Cost Structure Figure 71. PET Radiopharmaceuticals Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • F-18
  • Ru-82
  • Others
Applications
  • Neurology
  • Cardiology
  • Oncology
  • Others
Companies covered
  • Cardinal Health Inc. (U.S.)
  • Bayer AG (Germany)
  • Nordion, Inc. (Canada)
  • Mallinckrodt plc (Ireland)
  • Lantheus Medical Imaging, Inc. (U.S.)
  • IBA Molecular Imaging (Belgium)
  • GE Healthcare (U.K.)
  • Eczacibasi-Monrol Nuclear Products (Turkey)
  • Bracco Imaging S.p.A (Italy)
  • Advanced Accelerator Applications S.A. (France)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PET Radiopharmaceuticals Market by Type
  3. 1.2.1 Global PET Radiopharmaceuticals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 F-18
  5. 1.2.3 Ru-82
  6. 1.2.4 Others
  7. 1.3 PET Radiopharmaceuticals Market by Application
  8. 1.3.1 Global PET Radiopharmaceuticals Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Neurology
  10. 1.3.3 Cardiology
  11. 1.3.4 Oncology
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 PET Radiopharmaceuticals Market Dynamics
  1. 2.1 PET Radiopharmaceuticals Industry Trends
  2. 2.2 PET Radiopharmaceuticals Industry Drivers
  3. 2.3 PET Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 PET Radiopharmaceuticals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global PET Radiopharmaceuticals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global PET Radiopharmaceuticals Revenue by Region
  3. 3.2.1 Global PET Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PET Radiopharmaceuticals Revenue by Region (2021-2026)
  5. 3.2.3 Global PET Radiopharmaceuticals Revenue by Region (2027-2032)
  6. 3.2.4 Global PET Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global PET Radiopharmaceuticals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global PET Radiopharmaceuticals Sales by Region
  9. 3.4.1 Global PET Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global PET Radiopharmaceuticals Sales by Region (2021-2026)
  11. 3.4.3 Global PET Radiopharmaceuticals Sales by Region (2027-2032)
  12. 3.4.4 Global PET Radiopharmaceuticals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global PET Radiopharmaceuticals Revenue by Manufacturers
  2. 4.1.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global PET Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PET Radiopharmaceuticals Sales by Manufacturers
  6. 4.2.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global PET Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global PET Radiopharmaceuticals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global PET Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global PET Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global PET Radiopharmaceuticals Manufacturers, Product Type & Application
  13. 4.7 Global PET Radiopharmaceuticals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global PET Radiopharmaceuticals Market CR5 and HHI
  16. 4.8.2 2025 PET Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
5 PET Radiopharmaceuticals Market by Type
  1. 5.1 Global PET Radiopharmaceuticals Revenue by Type
  2. 5.1.1 Global PET Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global PET Radiopharmaceuticals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global PET Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global PET Radiopharmaceuticals Sales by Type
  6. 5.2.1 Global PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PET Radiopharmaceuticals Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global PET Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  9. 5.3 Global PET Radiopharmaceuticals Price by Type
6 PET Radiopharmaceuticals Market by Application
  1. 6.1 Global PET Radiopharmaceuticals Revenue by Application
  2. 6.1.1 Global PET Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global PET Radiopharmaceuticals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global PET Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global PET Radiopharmaceuticals Sales by Application
  6. 6.2.1 Global PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global PET Radiopharmaceuticals Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global PET Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 6.3 Global PET Radiopharmaceuticals Price by Application
7 Company Profiles
  1. 7.1 Cardinal Health Inc. (U.S.)
  2. 7.1.1 Cardinal Health Inc. (U.S.) Company Information
  3. 7.1.2 Cardinal Health Inc. (U.S.) Business Overview
  4. 7.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio
  6. 7.1.5 Cardinal Health Inc. (U.S.) Recent Developments
  7. 7.2 Bayer AG (Germany)
  8. 7.2.1 Bayer AG (Germany) Company Information
  9. 7.2.2 Bayer AG (Germany) Business Overview
  10. 7.2.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio
  12. 7.2.5 Bayer AG (Germany) Recent Developments
  13. 7.3 Nordion, Inc. (Canada)
  14. 7.3.1 Nordion, Inc. (Canada) Company Information
  15. 7.3.2 Nordion, Inc. (Canada) Business Overview
  16. 7.3.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolio
  18. 7.3.5 Nordion, Inc. (Canada) Recent Developments
  19. 7.4 Mallinckrodt plc (Ireland)
  20. 7.4.1 Mallinckrodt plc (Ireland) Company Information
  21. 7.4.2 Mallinckrodt plc (Ireland) Business Overview
  22. 7.4.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio
  24. 7.4.5 Mallinckrodt plc (Ireland) Recent Developments
  25. 7.5 Lantheus Medical Imaging, Inc. (U.S.)
  26. 7.5.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information
  27. 7.5.2 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
  28. 7.5.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio
  30. 7.5.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
  31. 7.6 IBA Molecular Imaging (Belgium)
  32. 7.6.1 IBA Molecular Imaging (Belgium) Company Information
  33. 7.6.2 IBA Molecular Imaging (Belgium) Business Overview
  34. 7.6.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio
  36. 7.6.5 IBA Molecular Imaging (Belgium) Recent Developments
  37. 7.7 GE Healthcare (U.K.)
  38. 7.7.1 GE Healthcare (U.K.) Company Information
  39. 7.7.2 GE Healthcare (U.K.) Business Overview
  40. 7.7.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolio
  42. 7.7.5 GE Healthcare (U.K.) Recent Developments
  43. 7.8 Eczacibasi-Monrol Nuclear Products (Turkey)
  44. 7.8.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information
  45. 7.8.2 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
  46. 7.8.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio
  48. 7.8.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
  49. 7.9 Bracco Imaging S.p.A (Italy)
  50. 7.9.1 Bracco Imaging S.p.A (Italy) Company Information
  51. 7.9.2 Bracco Imaging S.p.A (Italy) Business Overview
  52. 7.9.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolio
  54. 7.9.5 Bracco Imaging S.p.A (Italy) Recent Developments
  55. 7.10 Advanced Accelerator Applications S.A. (France)
  56. 7.10.1 Advanced Accelerator Applications S.A. (France) Company Information
  57. 7.10.2 Advanced Accelerator Applications S.A. (France) Business Overview
  58. 7.10.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolio
  60. 7.10.5 Advanced Accelerator Applications S.A. (France) Recent Developments
8 North America
  1. 8.1 North America PET Radiopharmaceuticals Market Size by Type
  2. 8.1.1 North America PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 8.1.2 North America PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 8.1.3 North America PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 8.2 North America PET Radiopharmaceuticals Market Size by Application
  6. 8.2.1 North America PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 8.2.2 North America PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 8.2.3 North America PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 8.3 North America PET Radiopharmaceuticals Market Size by Country
  10. 8.3.1 North America PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe PET Radiopharmaceuticals Market Size by Type
  2. 9.1.1 Europe PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 9.1.2 Europe PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 9.1.3 Europe PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 9.2 Europe PET Radiopharmaceuticals Market Size by Application
  6. 9.2.1 Europe PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 9.2.2 Europe PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 9.2.3 Europe PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 9.3 Europe PET Radiopharmaceuticals Market Size by Country
  10. 9.3.1 Europe PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China PET Radiopharmaceuticals Market Size by Type
  2. 10.1.1 China PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 10.1.2 China PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 10.1.3 China PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 10.2 China PET Radiopharmaceuticals Market Size by Application
  6. 10.2.1 China PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 10.2.2 China PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 10.2.3 China PET Radiopharmaceuticals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PET Radiopharmaceuticals Market Size by Type
  2. 11.1.1 Asia PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 11.1.2 Asia PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 11.1.3 Asia PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 11.2 Asia PET Radiopharmaceuticals Market Size by Application
  6. 11.2.1 Asia PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 11.2.2 Asia PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 11.2.3 Asia PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 11.3 Asia PET Radiopharmaceuticals Market Size by Country
  10. 11.3.1 Asia PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PET Radiopharmaceuticals Market Size by Type
  2. 12.1.1 SAMEA PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 12.2 SAMEA PET Radiopharmaceuticals Market Size by Application
  6. 12.2.1 SAMEA PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 12.3 SAMEA PET Radiopharmaceuticals Market Size by Country
  10. 12.3.1 SAMEA PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 PET Radiopharmaceuticals Value Chain Analysis
  2. 13.1.1 PET Radiopharmaceuticals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 PET Radiopharmaceuticals Production Mode & Process
  6. 13.2 PET Radiopharmaceuticals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 PET Radiopharmaceuticals Distributors
  9. 13.2.3 PET Radiopharmaceuticals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst